Escala Medical to Participate at ACCESS CHINA Biotech Forum

By Yafo Life Sciences

January 7th, 2022 (Shanghai) — We are glad to announce that Dennis Feldman, the Chief Commercial Officer of Escala Medical, has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan14th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.

If you are interested in listening to the live event, please register at https://biotochina.org/register/

About Escala Medical

Escala Medical is a femtech company based in Israel. Our vision is a better quality of life to all women, everywhere. We develop life-changing repair solutions for women with Pelvic Organ Prolapse, a condition that affects nearly 50% of all women. Our innovative, patented technology addresses a huge unmet need – it replaces surgery and will help millions of women worldwide regain an improved quality of life. We successfully completed our first clinical study and are expecting FDA clearance and CE approval during 2022.

Escala’s team combines proven leadership, innovation and experience in women’s healthcare.

About the speaker

Extensive experience in early stage medical device start-ups and company restructuring and turn-a rounds. Expertise in cutting-edge product introduction, market development, new territory development and cultivating trusting business partner relationships with physicians and customers.  Adept at understanding market challenges/ambiguities and a track record of exceeding sales goals, market share, and shareholders expectations.


ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/

Contact US

Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum

For more information, please contact:

Wendi Xiang